Sep 30, 2018

Adaptimmune Q3 2018 Earnings Report

Total Revenue
$40.8M
Previous year: $27.2M
+50.1%
EPS
$0.01
Previous year: -$0.00939
-206.5%
Gross Profit
$17.3M
Previous year: $3.15M
+449.3%
Cash and Equivalents
$153M
Previous year: $145M
+5.3%
Free Cash Flow
$9.26M
Previous year: $11.9M
-22.1%
Total Assets
$310M
Previous year: $301M
+2.7%

Adaptimmune

Adaptimmune